Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Cell wall-anchored 5'-nucleotidases in Gram-positive cocci.

Soh KY, Loh JMS, Proft T.

Mol Microbiol. 2019 Dec 24. doi: 10.1111/mmi.14442. [Epub ahead of print] Review.

PMID:
31872460
2.

Impact of Superantigen-Producing Bacteria on T Cells from Tonsillar Hyperplasia.

Radcliff FJ, Waldvogel-Thurlow S, Clow F, Mahadevan M, Johnston J, Li G, Proft T, Douglas RG, Fraser JD.

Pathogens. 2019 Jun 27;8(3). pii: E90. doi: 10.3390/pathogens8030090.

3.

Publisher Correction: Mucosal vaccination with pili from Group A Streptococcus expressed on Lactococcus lactis generates protective immune responses.

Loh JMS, Lorenz N, Tsai CJ, Khemlani AHJ, Proft T.

Sci Rep. 2019 May 1;9(1):6975. doi: 10.1038/s41598-019-43123-8.

4.

Group A Streptococcus T Antigens Have a Highly Conserved Structure Concealed under a Heterogeneous Surface That Has Implications for Vaccine Design.

Young PG, Raynes JM, Loh JM, Proft T, Baker EN, Moreland NJ.

Infect Immun. 2019 May 21;87(6). pii: e00205-19. doi: 10.1128/IAI.00205-19. Print 2019 Jun.

5.

Protein adhesins as vaccine antigens for Group A Streptococcus.

Raynes JM, Young PG, Proft T, Williamson DA, Baker EN, Moreland NJ.

Pathog Dis. 2018 Mar 1;76(2). doi: 10.1093/femspd/fty016. Review.

PMID:
29718270
6.

Orthologues of Streptococcus pyogenes nuclease A (SpnA) and Streptococcal 5'-nucleotidase A (S5nA) found in Streptococcus iniae.

Soh KY, Loh JMS, Proft T.

J Biochem. 2018 Aug 1;164(2):165-171. doi: 10.1093/jb/mvy039.

PMID:
29659850
7.

PilVax - a novel peptide delivery platform for the development of mucosal vaccines.

Wagachchi D, Tsai JC, Chalmers C, Blanchett S, Loh JMS, Proft T.

Sci Rep. 2018 Feb 7;8(1):2555. doi: 10.1038/s41598-018-20863-7.

8.

The novel Group A Streptococcus antigen SpnA combined with bead-based immunoassay technology improves streptococcal serology for the diagnosis of acute rheumatic fever.

Hanson-Manful P, Whitcombe AL, Young PG, Atatoa Carr PE, Bell A, Didsbury A, Mitchell EA, Dunbar PR, Proft T, Moreland NJ.

J Infect. 2018 Apr;76(4):361-368. doi: 10.1016/j.jinf.2017.12.008. Epub 2017 Dec 18.

PMID:
29269013
9.

Streptococcus pyogenes nuclease A (SpnA) mediated virulence does not exclusively depend on nuclease activity.

Chalmers C, Khemlani AHJ, Sohn CR, Loh JMS, Tsai CJ, Proft T.

J Microbiol Immunol Infect. 2017 Nov 13. pii: S1684-1182(17)30236-0. doi: 10.1016/j.jmii.2017.09.006. [Epub ahead of print]

10.

Artificial Urine for Teaching Urinalysis Concepts and Diagnosis of Urinary Tract Infection in the Medical Microbiology Laboratory.

Khan LB, Read HM, Ritchie SR, Proft T.

J Microbiol Biol Educ. 2017 Sep 1;18(2). pii: 18.2.46. doi: 10.1128/jmbe.v18i2.1325. eCollection 2017.

11.

Mucosal vaccination with pili from Group A Streptococcus expressed on Lactococcus lactis generates protective immune responses.

Loh JMS, Lorenz N, Tsai CJ, Khemlani AHJ, Proft T.

Sci Rep. 2017 Aug 3;7(1):7174. doi: 10.1038/s41598-017-07602-0. Erratum in: Sci Rep. 2019 May 1;9(1):6975.

12.

A potential role for staphylococcal and streptococcal superantigens in driving skewing of TCR Vβ subsets in tonsillar hyperplasia.

Radcliff FJ, Clow F, Mahadevan M, Johnston J, Proft T, Douglas RG, Fraser JD.

Med Microbiol Immunol. 2017 Aug;206(4):337-346. doi: 10.1007/s00430-017-0510-5. Epub 2017 May 4.

PMID:
28474248
13.

The ability of Group A streptococcus to adhere to immortalized human skin versus throat cell lines does not reflect their predicted tissue tropism.

Loh JMS, Tsai JC, Proft T.

Clin Microbiol Infect. 2017 Sep;23(9):677.e1-677.e3. doi: 10.1016/j.cmi.2017.03.011. Epub 2017 Mar 20.

14.

Development of a high-throughput opsonophagocytic assay for the determination of functional antibody activity against Streptococcus pyogenes using bioluminescence.

Lorenz N, Loh JM, Moreland NJ, Proft T.

J Microbiol Methods. 2017 Mar;134:58-61. doi: 10.1016/j.mimet.2017.01.010. Epub 2017 Jan 21.

PMID:
28115206
15.

The Group A Streptococcus serotype M2 pilus plays a role in host cell adhesion and immune evasion.

Tsai JC, Loh JM, Clow F, Lorenz N, Proft T.

Mol Microbiol. 2017 Jan;103(2):282-298. doi: 10.1111/mmi.13556. Epub 2016 Nov 14.

16.

Serological Evidence of Immune Priming by Group A Streptococci in Patients with Acute Rheumatic Fever.

Raynes JM, Frost HR, Williamson DA, Young PG, Baker EN, Steemson JD, Loh JM, Proft T, Dunbar PR, Atatoa Carr PE, Bell A, Moreland NJ.

Front Microbiol. 2016 Jul 22;7:1119. doi: 10.3389/fmicb.2016.01119. eCollection 2016.

17.

Streptococcal Superantigens: Biological properties and potential role in disease.

Proft T, Fraser JD.

In: Ferretti JJ, Stevens DL, Fischetti VA, editors. Streptococcus pyogenes : Basic Biology to Clinical Manifestations [Internet]. Oklahoma City (OK): University of Oklahoma Health Sciences Center; 2016-.
2016 Feb 10.

18.

Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing.

Tsai CJ, Loh JM, Proft T.

Virulence. 2016 Apr 2;7(3):214-29. doi: 10.1080/21505594.2015.1135289. Epub 2016 Jan 5. Review.

19.

Streptococcal 5'-Nucleotidase A (S5nA), a Novel Streptococcus pyogenes Virulence Factor That Facilitates Immune Evasion.

Zheng L, Khemlani A, Lorenz N, Loh JM, Langley RJ, Proft T.

J Biol Chem. 2015 Dec 25;290(52):31126-37. doi: 10.1074/jbc.M115.677443. Epub 2015 Nov 2.

20.

Stabilized plasmid-based system for bioluminescent labeling of multiple streptococcal species.

Loh JM, Proft T.

Biotechnol Lett. 2016 Jan;38(1):139-43. doi: 10.1007/s10529-015-1967-1. Epub 2015 Sep 26.

PMID:
26410784
21.

M-Protein Analysis of Streptococcus pyogenes Isolates Associated with Acute Rheumatic Fever in New Zealand.

Williamson DA, Smeesters PR, Steer AC, Steemson JD, Ng AC, Proft T, Fraser JD, Baker MG, Morgan J, Carter PE, Moreland NJ.

J Clin Microbiol. 2015 Nov;53(11):3618-20. doi: 10.1128/JCM.02129-15. Epub 2015 Aug 19.

22.

Increasing incidence of invasive group A streptococcus disease in New Zealand, 2002-2012: a national population-based study.

Williamson DA, Morgan J, Hope V, Fraser JD, Moreland NJ, Proft T, Mackereth G, Lennon D, Baker MG, Carter PE.

J Infect. 2015 Feb;70(2):127-34. doi: 10.1016/j.jinf.2014.09.001. Epub 2014 Sep 20.

PMID:
25246363
23.

Survey of the bp/tee genes from clinical group A streptococcus isolates in New Zealand - implications for vaccine development.

Steemson JD, Moreland NJ, Williamson D, Morgan J, Carter PE, Proft T.

J Med Microbiol. 2014 Dec;63(Pt 12):1670-8. doi: 10.1099/jmm.0.080804-0. Epub 2014 Sep 4.

PMID:
25190737
24.

Vaccination with Streptococcus pyogenes nuclease A stimulates a high antibody response but no protective immunity in a mouse model of infection.

Radcliff FJ, Fraser JD, Proft T.

Med Microbiol Immunol. 2015 Apr;204(2):185-91. doi: 10.1007/s00430-014-0353-2. Epub 2014 Aug 15.

PMID:
25119670
25.

Structure and activity of Streptococcus pyogenes SipA: a signal peptidase-like protein essential for pilus polymerisation.

Young PG, Proft T, Harris PW, Brimble MA, Baker EN.

PLoS One. 2014 Jun 9;9(6):e99135. doi: 10.1371/journal.pone.0099135. eCollection 2014.

26.

Working towards a group A streptococcal vaccine: report of a collaborative Trans-Tasman workshop.

Moreland NJ, Waddington CS, Williamson DA, Sriskandan S, Smeesters PR, Proft T, Steer AC, Walker MJ, Baker EN, Baker MG, Lennon D, Dunbar R, Carapetis J, Fraser JD.

Vaccine. 2014 Jun 24;32(30):3713-20. doi: 10.1016/j.vaccine.2014.05.017. Epub 2014 May 14.

PMID:
24837510
27.

Structural conservation, variability, and immunogenicity of the T6 backbone pilin of serotype M6 Streptococcus pyogenes.

Young PG, Moreland NJ, Loh JM, Bell A, Atatoa Carr P, Proft T, Baker EN.

Infect Immun. 2014 Jul;82(7):2949-57. doi: 10.1128/IAI.01706-14. Epub 2014 Apr 28.

28.

Molecular epidemiology of group A streptococcus from pharyngeal isolates in Auckland, New Zealand, 2013.

Williamson DA, Moreland NJ, Carter P, Upton A, Morgan J, Proft T, Lennon D, Baker MG, Dunbar R, Fraser JD.

N Z Med J. 2014 Jan 24;127(1388):55-60.

PMID:
24481387
29.

Comparison of firefly luciferase and NanoLuc luciferase for biophotonic labeling of group A Streptococcus.

Loh JM, Proft T.

Biotechnol Lett. 2014 Apr;36(4):829-34. doi: 10.1007/s10529-013-1423-z. Epub 2013 Dec 10.

PMID:
24322775
30.

Streptococcal superantigens: categorization and clinical associations.

Commons RJ, Smeesters PR, Proft T, Fraser JD, Robins-Browne R, Curtis N.

Trends Mol Med. 2014 Jan;20(1):48-62. doi: 10.1016/j.molmed.2013.10.004. Epub 2013 Nov 6. Review.

PMID:
24210845
31.

Toxin-antitoxin-stabilized reporter plasmids for biophotonic imaging of Group A streptococcus.

Loh JM, Proft T.

Appl Microbiol Biotechnol. 2013 Nov;97(22):9737-45. doi: 10.1007/s00253-013-5200-7. Epub 2013 Sep 6.

PMID:
24061415
32.

Galleria mellonella larvae as an infection model for group A streptococcus.

Loh JM, Adenwalla N, Wiles S, Proft T.

Virulence. 2013 Jul 1;4(5):419-28. doi: 10.4161/viru.24930. Epub 2013 May 7.

33.

Crystal structure of Spy0129, a Streptococcus pyogenes class B sortase involved in pilus assembly.

Kang HJ, Coulibaly F, Proft T, Baker EN.

PLoS One. 2011 Jan 11;6(1):e15969. doi: 10.1371/journal.pone.0015969.

34.

Functional analysis of Streptococcus pyogenes nuclease A (SpnA), a novel group A streptococcal virulence factor.

Chang A, Khemlani A, Kang H, Proft T.

Mol Microbiol. 2011 Mar;79(6):1629-42. doi: 10.1111/j.1365-2958.2011.07550.x. Epub 2011 Jan 26.

35.
36.

Crystal structure of the minor pilin FctB reveals determinants of Group A streptococcal pilus anchoring.

Linke C, Young PG, Kang HJ, Bunker RD, Middleditch MJ, Caradoc-Davies TT, Proft T, Baker EN.

J Biol Chem. 2010 Jun 25;285(26):20381-9. doi: 10.1074/jbc.M109.089680. Epub 2010 Apr 27.

37.

Purification, crystallization and preliminary crystallographic analysis of the minor pilin FctB from Streptococcus pyogenes.

Linke C, Young PG, Kang HJ, Proft T, Baker EN.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2010 Feb 1;66(Pt 2):177-9. doi: 10.1107/S1744309109051951. Epub 2010 Jan 28.

38.

Sortase-mediated protein ligation: an emerging biotechnology tool for protein modification and immobilisation.

Proft T.

Biotechnol Lett. 2010 Jan;32(1):1-10. doi: 10.1007/s10529-009-0116-0. Epub 2009 Sep 1. Review.

PMID:
19728105
39.

The laminin-binding protein Lbp from Streptococcus pyogenes is a zinc receptor.

Linke C, Caradoc-Davies TT, Young PG, Proft T, Baker EN.

J Bacteriol. 2009 Sep;191(18):5814-23. doi: 10.1128/JB.00485-09. Epub 2009 Jul 17.

40.

Isopeptide bonds in bacterial pili and their characterization by X-ray crystallography and mass spectrometry.

Kang HJ, Middleditch M, Proft T, Baker EN.

Biopolymers. 2009 Dec;91(12):1126-34. doi: 10.1002/bip.21170.

PMID:
19226623
41.

Pili in Gram-negative and Gram-positive bacteria - structure, assembly and their role in disease.

Proft T, Baker EN.

Cell Mol Life Sci. 2009 Feb;66(4):613-35. doi: 10.1007/s00018-008-8477-4. Review.

PMID:
18953686
42.

The bacterial superantigen and superantigen-like proteins.

Fraser JD, Proft T.

Immunol Rev. 2008 Oct;225:226-43. doi: 10.1111/j.1600-065X.2008.00681.x. Review.

PMID:
18837785
43.

Immobilization of proteins to biacore sensor chips using Staphylococcus aureus sortase A.

Clow F, Fraser JD, Proft T.

Biotechnol Lett. 2008 Sep;30(9):1603-7. doi: 10.1007/s10529-008-9718-1. Epub 2008 Apr 15.

PMID:
18414796
44.

Purification, crystallization and preliminary crystallographic analysis of Streptococcus pyogenes laminin-binding protein Lbp.

Linke C, Caradoc-Davies TT, Proft T, Baker EN.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2008 Feb 1;64(Pt 2):141-3. doi: 10.1107/S1744309108002273. Epub 2008 Jan 31.

45.

Stabilizing isopeptide bonds revealed in gram-positive bacterial pilus structure.

Kang HJ, Coulibaly F, Clow F, Proft T, Baker EN.

Science. 2007 Dec 7;318(5856):1625-8.

47.

Streptococcal superantigens.

Proft T, Fraser JD.

Chem Immunol Allergy. 2007;93:1-23. doi: 10.1159/000100851. Review.

PMID:
17369697
48.

Streptococcal mitogenic exotoxin, SmeZ, is the most susceptible M1T1 streptococcal superantigen to degradation by the streptococcal cysteine protease, SpeB.

Nooh MM, Aziz RK, Kotb M, Eroshkin A, Chuang WJ, Proft T, Kansal R.

J Biol Chem. 2006 Nov 17;281(46):35281-8. Epub 2006 Sep 15.

49.
50.

Involvement of streptococcal mitogenic exotoxin Z in streptococcal toxic shock syndrome.

Yang L, Thomas M, Woodhouse A, Martin D, Fraser JD, Proft T.

J Clin Microbiol. 2005 Jul;43(7):3570-3.

Supplemental Content

Support Center